GRCL News and Press, Gracell Biotechnologies Inc. From 10/17/22

Gracell Biotechnologies Doses First Patient in Phase 2 Portion of Registrational Phase 1/2 Clinical Trial Evaluating GC007g for Treatment of B-cell Acute Lymphoblastic Leukemia PR Newswire C linical trial assessing allogeneic, HLA-matched, donor-derived all...

Citi has initiated Gracell Biotechnologies ( NASDAQ: GRCL ) with a buy rating highlighting the speed of the company's autologous CAR-T platform manufacturing compared to competitors. The firm has a $12 price target (~422% upside based on Wednesday's close). Analyst Yig...

Gracell Biotechnologies Inc. (GRCL) Q2 2022 Earnings Conference Call August 15, 2022, 08:00 AM ET Company Participants Dr. Kevin Xie - CFO Dr. William Cao - Founder and CEO Dr. Wendy Li - Chief Medical Officer Conference Call Participants Joe Catanzar...

Gracell Biotechnologies press release ( NASDAQ: GRCL ): Q2 GAAP EPS of -$0.06 beats by $0.02 . As of June 30, 2022, the Company had RMB1,707.3 million (US$254.9 million) in cash and cash equivalents and short-term investments. In addition, For further details see...

Presented updated clinical data from an investigator-initiated trial (IIT) evaluating FasTCAR GC012F for the treatment of relapsed/refractory multiple myeloma (r/r MM) at ASCO and EHA 2022, which underscored the deep response with a 100% MRD negativity rate Presented first-in-...

Gracell Biotechnologies to Report Second Quarter 2022 Financial on Monday, August 15, 2022 PR Newswire SAN DIEGO, Calif. , and SUZHOU and SHANGHAI, China , Aug. 2, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a gl...

Gracell Biotechnologies ( NASDAQ: GRCL ) announced Monday the appointment of Wendy Li as its new chief medical officer. Li brings in over 20 years of experience in pharmaceutical industry across the US and China markets with expertise in leading early- and late-stage ...

Gracell Biotechnologies Appoints Accomplished Clinical Leader Dr. Wendy Li as Chief Medical Officer PR Newswire Dr. Li brings deep oncology clinical development, medical affairs and U.S. regulatory experience SAN DIEGO, Calif. and SUZHOU and SHANGHAI, Chi...

Gainers: Better Therapeutics BTTX +43% . GeoVax Labs ( GOVX ) +22% . Aridis Pharmaceuticals ( ARDS ) +19% . Comera Life Sciences ( CMRA ) +13% . Gracell Biotechnologies ( GRCL ) +13% . Losers: Community Health Systems ( CYH ...

Gracell Biotechnologies to Participate in BTIG 2022 Biotechnology Conference PR Newswire SAN DIEGO, Calif. , and SUZHOU and SHANGHAI, China , July 26, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global cli...